辅助生殖技术(ART)与其他出生儿的胎龄特异性围产期死亡率
这项基于澳大利亚五个州和领地2007-2009年数据的回顾性队列研究纳入407368名婴儿(391952名非ART和15416名ART),发现ART出生儿的总体围产期死亡率显著高于非ART出生儿(AOR 1.45,95%CI 1.26-1.68),但ART出生儿在极早产(<32周)和中晚期早产(32-36周)的胎龄特异性围产期死亡率低于非ART出生儿(AOR 0.61,95%CI 0.53-0.70)。作者认为早产是ART单胎围产期死亡风险增加的最重要因素,需要进一步研究减少早期早产。
要点
- ART出生儿总体围产期死亡率显著高于非ART出生儿(AOR 1.45,95%CI 1.26-1.68)。
- ART出生儿在极早产(<32周)和中晚期早产(32-36周)的胎龄特异性围产期死亡率低于非ART出生儿(AOR 0.61,95%CI 0.53-0.70)。
- 早产是ART单胎围产期死亡风险增加的最重要因素,作者建议进一步研究减少早期早产。
核心结论
- ART出生儿的总体围产期死亡率高于非ART出生儿,但ART出生儿在极早产和中晚期早产的胎龄特异性围产期死亡率低于非ART出生儿。
- 早产是ART单胎围产期死亡风险增加的最重要因素,作者认为需要进一步研究减少早期早产以降低ART出生儿的围产期死亡率。
研究设计与样本
- 这项基于人群的回顾性队列研究纳入407368名婴儿(391952名非ART和15416名ART),包括393491名单胎和10877名双胎或高价多胎。
- 研究纳入澳大利亚五个州和领地2007-2009年期间所有妊娠≥20周和/或出生体重≥400克的出生,数据来自国家围产期数据收集(NPDC)。
主要发现
- ART组的多胎出生率和低出生体重率显著高于非ART组(P < 0.01)。
- ART出生儿的总体围产期死亡率为16.5/1000出生(95%CI 14.5-18.6),非ART出生儿为11.3/1000出生(95%CI 11.0-11.6),AOR 1.45(95%CI 1.26-1.68)。
- ART出生儿(包括单胎和多胎)在极早产(<32周)和中晚期早产(32-36周)的胎龄特异性围产期死亡率低于非ART出生儿,AOR分别为0.61(95%CI 0.53-0.70)和0.61(95%CI 0.53-0.70)。
- 先天异常和自发性早产是ART组和非ART组新生儿死亡最常见的原因。
临床怎么用
- 作者认为需要进一步研究减少早期早产,以降低ART出生儿的围产期死亡率。
- 作者建议接受ART治疗的夫妇应充分了解早产风险及随后的围产期死亡风险。
局限性
- 由于澳大利亚围产期的切点限制与其他国家不同,本研究结果在应用于其他国家时应谨慎解读。
- 澳大利亚围产期定义从妊娠满20周(140天)开始至出生后满27天结束,不同于世界卫生组织(从妊娠满22周(154天)开始至出生后满7天结束)和美国疾病控制与预防中心(包括7天以下婴儿死亡和妊娠28周及以上胎儿死亡)的定义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is perinatal mortality rate higher among births born following assisted reproductive technology (ART) compared to non-ART births? SUMMARY ANSWER: Overall perinatal mortality rates in ART births was higher compared to non-ART births, but gestational age-specific perinatal mortality rate of ART births was lower for very preterm and moderate to late preterm births. WHAT IS KNOWN ALREADY: Births born following ART are reported to have higher risk of adverse perinatal outcomes compared to non-ART births. STUDY DESIGN, SIZE, DURATION: This population-based retrospective cohort study included 407 368 babies (391 952 non-ART and 15 416 ART)-393 491 singletons and 10 877 twins or high order multiples. PARTICIPANTS/MATERIALS, SETTING, METHODS: All births (≥20 weeks of gestation and/or ≥400 g of birthweight) in five states and territories in Australia during the period 2007-2009 were included in the study, using National Perinatal Data Collection (NPDC). Primary outcome measures were rates of stillbirth, neonatal and perinatal deaths. Adjusted odds ratio (AOR) and 95% confidence interval (CI) were used to estimate the likelihood of perinatal death. MAIN RESULTS AND THE ROLE OF CHANCE: Rates of multiple birth and low birthweight were significantly higher in ART group compared to the non-ART group (P < 0.01). Overall perinatal mortality rate was significantly higher for ART births (16.5 per 1000 births, 95% CI 14.5-18.6), compared to non-ART births (11.3 per 1000 births, 95% CI 11.0-11.6) (AOR 1.45, 95% CI 1.26-1.68). However, gestational age-specific perinatal mortality rate of ART births (including both singletons and multiples) was lower for very preterm (<32 weeks' gestation) and moderate to late preterm births (32-36 weeks' gestation) (AOR 0.61, 95% CI 0.53-0.70 and AOR 0.61, 95% CI 0.53-0.70, respectively) compared to non-ART births. Congenital abnormality and spontaneous preterm were the most common causes of neonatal deaths in both ART and non-ART group. LIMITATIONS, REASONS FOR CAUTION: Due to different cut-off limit for perinatal period in Australia, the results of this study should be interpreted with cautions for other countries. Australian definition of perinatal period commences at 20 completed weeks (140 days) of gestation and ends 27 completed days after birth which is different from the definition by World Health Organisation (commences at 22 completed weeks (154 days) of gestation and ends seven completed days after birth) and by Centers for Disease Control and Prevention (includes infant deaths under age 7 days and fetal deaths at 28 weeks of gestation or more). WIDER IMPLICATIONS OF THE FINDINGS: Preterm birth is the single most important contributing factor to increased risk of perinatal mortality among ART singletons compared to non-ART singletons. Further research on reducing early preterm delivery, with the aim of reducing the perinatal mortality among ART births is needed. Couples who access ART treatment should be fully informed regarding the risk of preterm birth and subsequent risk of perinatal death. STUDY FUNDING/COMPETING INTEREST(S): There was no funding associated with this study. No conflict of interest was declared.
引用
- Chughtai AA, Wang AY, Hilder L, et al. Gestational age-specific perinatal mortality rates for assisted reproductive technology (ART) and other births. Hum Reprod. 2018. PMID: 29140454. doi:10.1093/humrep/dex340
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。